Both in Pharmaceuticals
Erasca vs Cogent Biosciences
Over the past year ERAS returned +545.5% and COGT returned +122.9%; their daily moves had a correlation of 0.14.
ERAS +545.5% COGT +122.9%Growth of $1, one year, split-adjusted
| Metric | ERAS | COGT |
|---|---|---|
| Price | $14.91 | $31.49 |
| Market cap | $5.21B | $5.46B |
| Today | +1.84% | +1.38% |
| 1 month | +4.3% | +3.7% |
| 6 months | +36.8% | −12.2% |
| Year to date | +300.8% | −11.3% |
| 1 year | +526.5% | +103.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $268.7M | $568.8M |
| Dividend yield | — | — |
| Volatility (60d) | 59.7% | 39.1% |
| Short % of float | 14.5% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).